Joe McCann, Point Biopharma CEO (via Point)

Point un­veils new In­dy site to shore up sup­ply chain in fight against prostate can­cer

With a new man­u­fac­tur­ing fa­cil­i­ty and a can­di­date for prostate can­cer in clin­i­cal tri­als, Point Bio­phar­ma is mov­ing fast to bring its ra­di­oli­gand op­er­a­tions on­line …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.